Most adults in the US would take a blood test to assess whether they will develop Alzheimer's, according to the survey, ...

The company said it took financial hits from the Inflation Reduction Act's Medicare Part D redesign, which included higher ...

The cost savings will allow the firm to hire new employees who can support clinical trials of its DMD candidates and advance other therapeutic programs.

When patients with solid tumors had the same liquid- and tissue-based test findings, patients had better outcomes on molecular tumor board-guided therapy.

Researchers at AACR's annual meeting said they hope the vaccine will show stronger efficacy in patients with minimal residual disease.

In a Phase I study presented at AACR's annual meeting, 71 percent of patients who hadn't received a prior anti-HER2 ADC responded to the drug.